Skip to content

Commit 20f4937

Browse files
authored
add codecov badge [skip ci] (#588)
Adds a codecov badge to the README Signed-off-by: Peter St. John <pstjohn@nvidia.com>
1 parent c691df2 commit 20f4937

File tree

3 files changed

+3
-27
lines changed

3 files changed

+3
-27
lines changed

.github/workflows/pre-commit.yml

Lines changed: 0 additions & 26 deletions
This file was deleted.

.github/workflows/unit-tests.yml

Lines changed: 1 addition & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -37,6 +37,7 @@ jobs:
3737
build-bionemo-image:
3838
needs: pre-commit
3939
runs-on: self-hosted-azure-cpu
40+
if: ${{ !contains(github.event.pull_request.labels.*.name, 'SKIP_CI') }}
4041
steps:
4142
- name: Checkout repository
4243
uses: actions/checkout@v4

README.md

Lines changed: 2 additions & 1 deletion
Original file line numberDiff line numberDiff line change
@@ -2,7 +2,8 @@
22

33
[![Click here to deploy.](https://uohmivykqgnnbiouffke.supabase.co/storage/v1/object/public/landingpage/brevdeploynavy.svg)](https://console.brev.dev/launchable/deploy/now?launchableID=env-2pPDA4sJyTuFf3KsCv5KWRbuVlU)
44
[![Docs Build](https://img.shields.io/github/actions/workflow/status/NVIDIA/bionemo-framework/pages/pages-build-deployment?label=docs-build)](https://nvidia.github.io/bionemo-framework)
5-
![Latest Tag](https://img.shields.io/github/v/tag/NVIDIA/bionemo-framework?label=latest-version)
5+
[![Latest Tag](https://img.shields.io/github/v/tag/NVIDIA/bionemo-framework?label=latest-version)](https://catalog.ngc.nvidia.com/orgs/nvidia/teams/clara/containers/bionemo-framework/tags)
6+
[![codecov](https://codecov.io/gh/NVIDIA/bionemo-framework/branch/main/graph/badge.svg?token=XqhegdZRqB)](https://codecov.io/gh/NVIDIA/bionemo-framework)
67

78
NVIDIA BioNeMo Framework is a collection of programming tools, libraries, and models for computational drug discovery.
89
It accelerates the most time-consuming and costly stages of building and adapting biomolecular AI models by providing

0 commit comments

Comments
 (0)